These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2738887)

  • 1. Binary antidotes for organophosphate poisoning: aprophen analogues that are both antimuscarinics and carbamates.
    Leader H; Smejkal RM; Payne CS; Padilla FN; Doctor BP; Gordon RK; Chiang PK
    J Med Chem; 1989 Jul; 32(7):1522-8. PubMed ID: 2738887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors.
    Leader H; Wolfe AD; Chiang PK; Gordon RK
    J Med Chem; 2002 Feb; 45(4):902-10. PubMed ID: 11831902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of poisoning by soman.
    Leadbeater L; Inns RH; Rylands JM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S225-31. PubMed ID: 4092890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats.
    Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M
    Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
    Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
    Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desethylaprophen: a metabolite of aprophen with antimuscarinic activities.
    Brown ND; Smejkal RM; Breuer E; Doctor BP; Chiang PK
    J Pharm Sci; 1988 Feb; 77(2):145-8. PubMed ID: 3258910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic investigations into the interactions of aprophen with cholinesterases and a carboxylesterase.
    Rush RS; Doctor BP; Wolfe AD
    Biochem Pharmacol; 1986 Dec; 35(23):4167-70. PubMed ID: 3098245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprophen: a substrate and inhibitor of butyrylcholinesterase and carboxylesterases.
    Rush RS; Ralston JS; Wolfe AD
    Biochem Pharmacol; 1985 Jun; 34(12):2063-8. PubMed ID: 4004924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organophosphate and carbamate poisoning.
    King AM; Aaron CK
    Emerg Med Clin North Am; 2015 Feb; 33(1):133-51. PubMed ID: 25455666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidotes or organophosphate poisoning. 2. Thiadiazole-5-carboxaldoximes.
    Benschop HP; Van den Berg GR; Van Hooidonk C; De Jong LP; Kientz CE; Berends F; Kepner LA; Meeter E; Visser RP
    J Med Chem; 1979 Nov; 22(11):1306-13. PubMed ID: 533877
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
    Yu QS; Atack JR; Rapoport SI; Brossi A
    FEBS Lett; 1988 Jul; 234(1):127-30. PubMed ID: 3391264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
    Leader H; Gordon RK; Baumgold J; Boyd VL; Newman AH; Smejkal RM; Chiang PK
    J Med Chem; 1992 Apr; 35(7):1290-5. PubMed ID: 1560441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
    Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
    Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate.
    Berry WK; Davies DR
    Biochem Pharmacol; 1970 Mar; 19(3):927-34. PubMed ID: 5507697
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
    Genovese RF; Elsmore TF; Witkin JM
    Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of aprophen, atropine and benactyzine on central and peripheral cholinoceptors and on acetylcholinesterase.
    Dawson RM; Freeman SE; Paddle BM
    Biochem Pharmacol; 1985 May; 34(9):1577-9. PubMed ID: 3994766
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
    Herkert NM; Thiermann H; Worek F
    Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM; Gordon RK; Chiang PK
    J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compounds.
    Green AL
    Biochem Pharmacol; 1983 Jun; 32(11):1717-22. PubMed ID: 6870912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.